Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.37B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$488M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$449M |
| 4 |
Apple
AAPL
|
+$402M |
| 5 |
HES
Hess
HES
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.47B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$1.44B |
| 3 |
NVIDIA
NVDA
|
+$783M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$722M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$650M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Healthcare | 6.09% |
| 3 | Financials | 5% |
| 4 | Consumer Discretionary | 4.53% |
| 5 | Industrials | 4.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWTX
3876
DELISTED
SpringWorks Therapeutics
SWTX
| $1.25M | ﹤0.01% |
34,205
-80,718
| -70% | -$2.11M |
|
|
NSTG
3877
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.25M | ﹤0.01% |
1,665,199
+564,731
| +51% | +$597K |
|
3878
Camden National
CAC
$978M
| $1.24M | ﹤0.01% |
33,071
-16,742
| -34% | -$546K |
|
3879
Designer Brands
DBI
$307M
| $1.24M | ﹤0.01% |
140,617
+3,890
| +3% | +$40.9K |
|
3880
Turkcell
TKC
$4.68B
| $1.24M | ﹤0.01% |
258,663
+122,576
| +90% | +$576K |
|
|
PGRE
3881
DELISTED
Paramount Group
PGRE
| $1.24M | ﹤0.01% |
240,379
-29,233
| -11% | -$139K |
|
|
GBIO
3882
DELISTED
Generation Bio
GBIO
| $1.24M | ﹤0.01% |
75,275
+72,208
| +2,354% | +$1.26M |
|
3883
Bioventus
BVS
$892M
| $1.24M | ﹤0.01% |
235,483
-104,693
| -31% | -$414K |
|
3884
PUT
Avis
CAR
$4.86B
| $1.24M | ﹤0.01% |
7,000
-11,400
| -62% | -$2.08M |
|
3885
CALL
OneMain Financial
OMF
$7.2B
| $1.24M | ﹤0.01% |
+25,200
| New | +$1.03M |
|
|
3886
PUT
OneMain Financial
OMF
$7.2B
| $1.24M | ﹤0.01% |
25,200
-74,800
| -75% | -$3.05M |
|
3887
CALL
Baxter International
BAX
$13.5B
| $1.24M | ﹤0.01% |
+32,000
| New | +$1.13M |
|
|
BRSP
3888
BrightSpire Capital
BRSP
$634M
| $1.23M | ﹤0.01% |
165,551
-56,038
| -25% | -$366K |
|
3889
Eagle Materials
EXP
$6.29B
| $1.23M | ﹤0.01% |
6,071
-5,750
| -49% | -$1.01M |
|
3890
CytomX Therapeutics
CTMX
$675M
| $1.23M | ﹤0.01% |
794,047
+95,141
| +14% | +$125K |
|
3891
ANI Pharmaceuticals
ANIP
$1.8B
| $1.23M | ﹤0.01% |
+22,300
| New | +$1.23M |
|
3892
PUT
Molina Healthcare
MOH
$10.2B
| $1.23M | ﹤0.01% |
3,400
-2,800
| -45% | -$988K |
|
3893
Highwoods Properties
HIW
$3.65B
| $1.23M | ﹤0.01% |
53,450
-496,945
| -90% | -$9.9M |
|
|
SILK
3894
PUT
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.23M | ﹤0.01% |
+100,000
| New | +$938K |
|
3895
Brink's
BCO
$4.88B
| $1.23M | ﹤0.01% |
13,932
-14,786
| -51% | -$1.14M |
|
3896
PUT
Virgin Galactic
SPCE
$328M
| $1.23M | ﹤0.01% |
+25,000
| New | +$987K |
|
3897
Olema Pharmaceuticals
OLMA
$1B
| $1.22M | ﹤0.01% |
87,252
-126,842
| -59% | -$1.7M |
|
3898
PUT
Synaptics
SYNA
$4.19B
| $1.22M | ﹤0.01% |
10,700
+6,000
| +128% | +$596K |
|
3899
PUT
First Horizon
FHN
$12.2B
| $1.22M | ﹤0.01% |
86,100
-466,700
| -84% | -$5.62M |
|
|
CSR
3900
Centerspace
CSR
$921M
| $1.22M | ﹤0.01% |
20,947
+12,226
| +140% | +$668K |
|
Similar funds
Millennium Management's Q4 2023 Portfolio in Review
As of Q4 2023, Millennium Management held 6,891 positions worth $231B, up 17% from $198B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Millennium Management deployed $7.99B of net new capital in Q4 2023, opening 816 new positions and adding to 2,304 existing holdings. Its largest new stake was Ferguson: 906,589 shares worth $175M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 9.2% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.47B trimmed.
- Millennium Management's largest Q4 2023 buy was Ferguson: 906,589 shares worth $175M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $4.37B increase.
- Millennium Management's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.47B.
- Millennium Management fully exited Activision Blizzard in Q4 2023, selling an estimated $1.44B.
- Millennium Management's ten largest holdings make up 21% of its $231B portfolio in Q4 2023.
- Millennium Management opened 816 new positions and closed 883 in Q4 2023.
- Millennium Management's portfolio value rose 17% quarter-over-quarter to $231B.
Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.